Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Vaccine - Page 55

Vaccine

Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO

Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine

On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…

Read More Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccineContinue

Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidate

On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…

Read More Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidateContinue

AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityメs vaccine at no profit
COVID-19 | Life Science History | Vaccine

AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityメs vaccine at no profit

On Jun. 13, 2020, AstraZeneca announced an agreement with Europeメs Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…

Read More AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityメs vaccine at no profitContinue

Sinovac announced positive preliminary results of phase I/II clinical trials for inactivated vaccine candidate against COVID-19
COVID-19 | Life Science History | Vaccine

Sinovac announced positive preliminary results of phase I/II clinical trials for inactivated vaccine candidate against COVID-19

On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Companyメs…

Read More Sinovac announced positive preliminary results of phase I/II clinical trials for inactivated vaccine candidate against COVID-19Continue

Sinovac and Butantan joined efforts to advance clinical development of an inactivated vaccine for COVID-19 to phase III
COVID-19 | Life Science History | Vaccine

Sinovac and Butantan joined efforts to advance clinical development of an inactivated vaccine for COVID-19 to phase III

On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…

Read More Sinovac and Butantan joined efforts to advance clinical development of an inactivated vaccine for COVID-19 to phase IIIContinue

Emergent BioSolutions signed agreement to be US manufacturing partner for AstraZenecaメs COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Emergent BioSolutions signed agreement to be US manufacturing partner for AstraZenecaメs COVID-19 vaccine candidate

On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…

Read More Emergent BioSolutions signed agreement to be US manufacturing partner for AstraZenecaメs COVID-19 vaccine candidateContinue

Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19

On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…

Read More Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19Continue

Johnson & Johnson announced acceleration of its COVID-19 vaccine candidate with phase 1/2a clinical trial
Life Science History | Vaccine

Johnson & Johnson announced acceleration of its COVID-19 vaccine candidate with phase 1/2a clinical trial

On Jun. 10, 2020, Johnson & Johnson announced that through its Janssen Pharmaceutical subsidiary it has accelerated the…

Read More Johnson & Johnson announced acceleration of its COVID-19 vaccine candidate with phase 1/2a clinical trialContinue

Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform
Biotechnology | COVID-19 | Life Science History | Vaccine

Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform

On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…

Read More Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platformContinue

Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology
Biotechnology | Infectious Disease | Influenza | Vaccine

Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology

On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…

Read More Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technologyContinue

Unique biorepository stores samples from Alberta COVID-19 patients for future research
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Unique biorepository stores samples from Alberta COVID-19 patients for future research

On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…

Read More Unique biorepository stores samples from Alberta COVID-19 patients for future researchContinue

The UK Global Vaccine Summit secured $74 billion in funding to support global vaccine supply and immunisation
Life Science History | Vaccine

The UK Global Vaccine Summit secured $74 billion in funding to support global vaccine supply and immunisation

On Jun. 5, 2020, the UK thelped secure $7.4 billion in funding to support global vaccine supply and…

Read More The UK Global Vaccine Summit secured $74 billion in funding to support global vaccine supply and immunisationContinue

University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidate
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidate

On Jun. 5, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ)…

Read More University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidateContinue

WHO announced new funding for vaccines
Life Science History | Vaccine | WHO

WHO announced new funding for vaccines

On Jun. 4, 2020, the WHO announced new pledges that will enable Gavi to protect the next generation…

Read More WHO announced new funding for vaccinesContinue

Novavax awarded Department of Defense contract for COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax awarded Department of Defense contract for COVID-19 vaccine

On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…

Read More Novavax awarded Department of Defense contract for COVID-19 vaccineContinue

INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea

On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…

Read More INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South KoreaContinue

iBio announced second COVID-19 vaccine program
COVID-19 | Life Science History | Vaccine

iBio announced second COVID-19 vaccine program

On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….

Read More iBio announced second COVID-19 vaccine programContinue

World leaders made historic commitments to provide equal access to vaccines for all
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Measles | Polio | Vaccine

World leaders made historic commitments to provide equal access to vaccines for all

On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…

Read More World leaders made historic commitments to provide equal access to vaccines for allContinue

HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries
Life Science History | Vaccine

HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries

On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…

Read More HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countriesContinue

The Gates Foundation pledged $16 billion to Gavi, the Vaccine Alliance, to protect the next generation with vaccines
COVID-19 | Non-Profit Research | Vaccine

The Gates Foundation pledged $16 billion to Gavi, the Vaccine Alliance, to protect the next generation with vaccines

On Jun. 4, 2020, the Bill & Melinda Gates Foundation announced a five-year, US$1.6 billion commitment to Gavi,…

Read More The Gates Foundation pledged $16 billion to Gavi, the Vaccine Alliance, to protect the next generation with vaccinesContinue

HPV vaccine manufacturers committed to immunise at least 84 million girls in Gavi countries
Life Science History | Vaccine

HPV vaccine manufacturers committed to immunise at least 84 million girls in Gavi countries

On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax pledged to…

Read More HPV vaccine manufacturers committed to immunise at least 84 million girls in Gavi countriesContinue

WHO welcomed crucial new funding for vaccines
Biotechnology | Vaccine | WHO

WHO welcomed crucial new funding for vaccines

On Jun. 4, 2020, the World Health Organization (WHO) welcomed funding commitments from Gavi, the Vaccine Alliance’s third…

Read More WHO welcomed crucial new funding for vaccinesContinue

AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccine
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics | Vaccine

AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccine

On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…

Read More AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccineContinue

CEPI granted $141 million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
Biotechnology | COVID-19 | Vaccine

CEPI granted $141 million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPI

On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…

Read More CEPI granted $141 million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPIContinue

Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
COVID-19 | Life Science History | Vaccine

Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines

On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….

Read More Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccinesContinue

Emergent BioSolutions joined U.S. Government’s Warp Speed Program  for COVID-19 vaccine development and manufacturing
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing

On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…

Read More Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturingContinue

Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be Manufacturing partner for COVID-19 vaccine candidate TNX-1800
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be Manufacturing partner for COVID-19 vaccine candidate TNX-1800

On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…

Read More Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be Manufacturing partner for COVID-19 vaccine candidate TNX-1800Continue

International community rallied to support open research and science to fight COVID-19
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Therapeutics | Vaccine

International community rallied to support open research and science to fight COVID-19

On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…

Read More International community rallied to support open research and science to fight COVID-19Continue

Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel Coronavirus
Biotechnology | Infectious Disease | Vaccine

Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel Coronavirus

On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…

Read More Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel CoronavirusContinue

Johnson & Johnson received positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen
Pharmaceutical | Therapeutics | Vaccine

Johnson & Johnson received positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen

On May 29, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…

Read More Johnson & Johnson received positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimenContinue

Page navigation

Previous PagePrevious 1 … 53 54 55 56 57 … 78 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search